Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,502 | -3,380 | -6,700 | -4,564 | -4,265 |
| Depreciation Amortization | 2 | 1 | 4 | 3 | 138 |
| Accounts payable and accrued liabilities | 642 | 464 | 140 | -61 | -162 |
| Other Working Capital | 1,587 | 1,275 | -394 | -121 | -952 |
| Other Operating Activity | -487 | -433 | -8 | 170 | 666 |
| Operating Cash Flow | $-4,758 | $-2,073 | $-6,958 | $-4,574 | $-4,574 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -2 | -2 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | -1 |
| Investing Cash Flow | $N/A | $N/A | $-2 | $-2 | $-1 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,500 | 3,125 | N/A | N/A | N/A |
| Other Financing Activity | -68 | -63 | 7,995 | 7,995 | -161 |
| Financing Cash Flow | $5,432 | $3,062 | $7,995 | $7,995 | $-161 |
| Beginning Cash Position | 1,834 | 1,834 | 799 | 799 | 12,584 |
| End Cash Position | 2,508 | 2,823 | 1,834 | 4,218 | 7,847 |
| Net Cash Flow | $674 | $989 | $1,036 | $3,419 | $-4,736 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,758 | -2,073 | -6,958 | -4,574 | -4,574 |
| Capital Expenditure | N/A | N/A | -2 | -2 | N/A |
| Free Cash Flow | -4,758 | -2,073 | -6,959 | -4,576 | -4,574 |